RITUXIMAB MAINTENANCE AFTER NORDIC PROTOCOL (R‐MAXICHOP/HD‐ARAC/ASCT) SIGNIFICANTLY PROLONGS SURVIVAL IN YOUNG MANTLE CELL LYMPHOMA PATIENTS. (June 2017) - Klener, P.; Salek, D.; Mocikova, H.; Blahovcova, P.; Pytlik, R.; Janikova, A.; Prochazka, V.; Campr, V.; Boudova, L.; Jaksa, R.; Kodet, R.; Trneny, M.